Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Scott Cole (NPI 1346351004)

Field	Value
Entity Type	Individual
Organization	Scott Cole
Address	12697 E 51st St
City	Tulsa
State	OK
ZIP	74146
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 31, 2006

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

SCOTT COLE is enumerated as an NPI since 2006-08-31, indicating roughly 20 years of presence in Medicare billing; that tenure supports experience in hematology/oncology care delivery and likely established referral relationships in the Tulsa, OK market. The taxonomy listed is Hematology & Oncology Physician, which aligns with the predominance of infused oncology drugs and high-intensity imaging in the claims mix.

Medicare is effectively the sole payer in this profile: lifetime Medicare revenue is $2.3M while there is no Medicaid billing on file, making this provider functionally single-payer from payers represented in the dataset. Analysts should treat Medicaid-related competitive or access questions as not addressable from these claims because there is no in-state Medicaid activity to evaluate.

Revenue concentration is high: the precomputed top 3 Medicare codes account for 47.4% of the provider’s total Medicare revenue, indicating that a small set of services — specifically high-cost oncology infusions and specialty immunotherapies — drive nearly half of billed Medicare dollars. This concentration suggests the practice’s commercial and operational focus is on administering expensive biologic and immuno-oncology agents.

The single largest Medicare revenue contributor is J9271 (pembrolizumab) with $430K in revenue (20.1% of Medicare revenue), and J9144 (daratumumab) and J9299 (nivolumab) are the second and third largest contributors. The presence of multiple high-revenue immune-oncology and monoclonal antibody codes in the top slots reinforces that infusion oncology and systemic therapy administration are core service lines for this provider.

Competitive standing by national rank is modest to typical for most high-revenue drug codes: J9271 ranks in the 35th percentile nationally (described as typical, unremarkable volume), J9144 sits at the 46th percentile, and J9299 at the 42th percentile, indicating the provider is not a national leader in volume for these agents but maintains regular, routine use consistent with many peer oncologists. However, several E/M codes (99214 and 99215) and high-complexity new-visit 99205 rank in the 96–97th percentiles (notably above typical national volume), suggesting this clinician bills a higher-than-typical share of mid- and high-complexity office encounters relative to national peers.

Imaging and diagnostic support features prominently: PET/CT-related codes 78815 and 78816, and radiotracer supply code A9552, together account for meaningful revenue shares (e.g., 78815 is $216.1K, 10.1% of Medicare revenue), and these codes rank at solid national percentiles (78815 at 85th, 78816 at 77th, A9552 at 90th percentile). That pattern indicates in-house or tightly integrated access to PET/CT imaging for staging and treatment monitoring, which is consistent with an oncology-focused practice model.

Laboratory and supportive care codes also show concentrated operational throughput: panels like 80053 and 85025 and specialty supportive drugs such as J1627 (granisetron), J1569 (immune globulin), and J1930 (lanreotide) appear in the top 25 and, for several lab codes, the provider ranks in the high national percentiles (e.g., 80053 and 85025 in the 98th percentile). This suggests routine monitoring and supportive-care workflows co-located with infusion services, enabling longitudinal oncologic care.

There are sparse appearances of biosimilars and lower-priced agents (Q5126, Q5118, Q5116) with relatively low national percentile ranks in some cases (e.g., Q5126 at the 4th percentile, Q5118 at the 7th percentile), which may reflect formulary choice, procurement channels, or local prescribing patterns rather than high-volume biosimilar adoption. These positions mark the provider as a modest participant nationally for those specific biosimilar products.

Overall, the data describe a long-tenured hematology/oncology physician in Tulsa whose Medicare revenue of $2.3M is concentrated in high-cost infused oncology drugs and PET/CT imaging, with strong relative volumes for mid- and high-complexity office visits but no Medicaid revenue to evaluate payer diversification or state-level Medicaid competitiveness. This profile is consistent with a focused oncology infusion practice that handles complex visits and in-depth diagnostic imaging but is not a top national-volume center for the headline immunotherapy agents.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

98 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	10,000	$40	$430K
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	7,740	$40	$294.1K
J9299	Injection, nivolumab, 1 mg	12,720	$20	$292.6K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	210	$1,030	$216.1K
J1930	Injection, lanreotide, 1 mg	4,680	$40	$205.9K
J1449	Injection, eflapegrastim-xnst, 0.1 mg	2,900	$30	$72.6K
Q5126	Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg	1,340	$50	$72.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	810	$80	$64.5K
78816	The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The…	50	$1,030	$55.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	370	$130	$45.9K

Showing 1–10 of 98

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 98 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Scott Cole — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

98 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	10	10,600	$40	$466.9K
J9299	6	10	14,050	$20	$324.4K
J9144	1	10	6,480	$40	$248.5K
J1930	2	10	2,910	$40	$137.2K
J1569	15	20	3,670	$30	$125.8K
J0897	42	70	2,130	$20	$91.2K
J1449	5	10	3,040	$30	$78.5K
Q5126	1	10	1,340	$50	$73K
Q5118	5	10	1,480	$30	$37.8K
J1627	5	10	6,100	$1	$30.1K

Showing 1–10 of 98

Related Providers

Other providers that share a Tax Identification Number (TIN) with Scott Cole, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stillwater Medical Center Authority	OK	General Acute Care Hospital	$0	$15.7M
Stillwater Medical Center Authority	OK	Family Medicine Physician	$0	$13.2M
Stillwater Medical Center Authority	OK	Rural Acute Care Hospital	$0	$3.3M
Grenville Jones	ME	Therapeutic Radiology Physician	$2.8M	$0
Charles Taylor	OK	Hematology & Oncology Physician	$2.3M	$0
Mark Olsen	OK	Hematology & Oncology Physician	$2.2M	$0
Paul Zito	OK	Hematology & Oncology Physician	$2.2M	$0
Melinda Dunlap	OK	Hematology & Oncology Physician	$2.1M	$0
Mark Jennings	TX	Internal Medicine Physician	$2.1M	$0
Oklahoma Cancer Specialists And Research Institute LLC	OK	Hematology & Oncology Physician	$0	$1.7M

Nearby Providers

Other providers in the same ZIP code as Scott Cole, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Option 1 Nutrition Solutions LLC	OK	Durable Medical Equipment & Medical Supplies	$0	$18.8M
Regional Medical Laboratory, Inc	OK	Clinical Medical Laboratory	$0	$17.6M
Labcorp Oklahoma, Inc.	OK	Clinical Medical Laboratory	$6.8M	$7.8M
Access Pain Solutions	OK	Pain Medicine Physician	$0	$13.1M
Osu Center For Health Sciences	OK	Medical Specialty Clinic/Center	$0	$10.5M
Advanced Pediatric Care	OK	Durable Medical Equipment & Medical Supplies	$0	$4.9M
Asm LLC	OK	Customized Equipment (DME)	$0	$4.7M
Pathology Laboratory Associates, Inc.	OK	Anatomic Pathology & Clinical Pathology Physician	$22.2K	$3.9M
Sleep Management, L.L.C.	OK	Oxygen Equipment & Supplies (DME)	$0	$3.6M
Tulsa Bone & Joint Associates PC	OK	Orthopaedic Surgery Physician	$0	$3M

Scott Cole — Billing Profile & Reimbursement Data

Sign up for Scott Cole — Billing Profile & Reimbursement Data policy alerts

Scott Cole — Billing Profile & Reimbursement Data

Sign up for Scott Cole — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References